<?xml version="1.0" encoding="UTF-8"?>
<XML><RECORDS>
<RECORD>
	<REFERENCE_TYPE>0</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>Bajaj S</AUTHOR>
		<AUTHOR>Srinivasan BP</AUTHOR>
	</AUTHORS>
	<YEAR>1999</YEAR>
	<TITLE>Investigations into anti-diabetic activity of A. indica</TITLE>
	<SECONDARY_TITLE>Indian Journal of Pharmacology</SECONDARY_TITLE>
	<VOLUME>31</VOLUME>
	<NUMBER>2</NUMBER>
	<PAGES>4</PAGES>
	<KEYWORDS>
		<KEYWORD>Diabetes</KEYWORD>
		<KEYWORD>Mellitus/DT,</KEYWORD>
		<KEYWORD>Diabetes</KEYWORD>
		<KEYWORD>Mellitus,</KEYWORD>
		<KEYWORD>Insulin-Dependent,</KEYWORD>
		<KEYWORD></KEYWORD>
		<KEYWORD>Non-Insulin-Dependent,Rats,</KEYWORD>
		<KEYWORD>Hyperglycemic</KEYWORD>
		<KEYWORD>Agents,</KEYWORD>
		<KEYWORD>Streptozocin/AD,</KEYWORD>
		<KEYWORD>Data</KEYWORD>
		<KEYWORD>Interpretation,</KEYWORD>
		<KEYWORD>Statistical,Animal,</KEYWORD>
		<KEYWORD>Male</KEYWORD>
	</KEYWORDS>
	<ABSTRACT>Objective: 

To investigate the anti-diabetic activity of Azadirachta Indica using IDDM and NIDDM animal models. Methods: Streptozotocin induced models of IDDM (65 mg/kg,iv) as well as NIDDM model (90 mg/kg,i.p in neonates) were given neem leaf extract (NLE, 1 g/kg, po) for 6 weeks and their anti-diabetic activity was assessed. 

Result: 

The treatment with insulin, aqueous NLE, aqueous NLE with insulin and insulin with aminoguanidine showed a fall in blood glucose levels of 80,45,4,38, 02 and 77-65 percent whereas in NIDDM model, a fall of 53.95 and 60.50 percent were observed with glibenclamide and NLE. Conclusion: Aqueous extract of NLE has a good therapeutic potential as anti-hyperglycaemic agent in IDDM and NIDDM. </ABSTRACT>
</RECORD>
</RECORDS></XML>